New Corporate Alliances & Conferences

BioMark is actively pursuing international business and research collaborations to increase its global footprint.

North America

N. America is a critical market for technology development and commercial acceleration. BioMark is in discussions with 4 potential companies located in Boston, Maryland, San Diego and San Francisco. Both the East and West coast corridors are important centres for biotechnology and medical device markets


BioMark’s international partners are located in China, Bangladesh (Fastbios and NCI), South Africa (Atkis) and Oman (Barik Group). These international partners have strong operating infrastructure and expertise in clinical research and development. The partners will play a critical role in product launch in each of their respective market or region.


International BioMark Offices

Head Office – 165 – 10551 Shellbridge Way Richmond, BC Canada

Winnipeg, Manitoba – Room # RL008  St. Boniface General Hospital Research Centre
351 Tache Avenue Winnipeg, Manitoba R2H 2A6


Upcoming Conferences

Health Tech Connexx – Surrey British Columbia


Upcoming Raman Spectrometer Related Conferences

1. Strategies in Biophotonics,  SEPTEMBER 9-11, 2014 – BOSTON PARK PLAZA HOTEL, BOSTON, MASSACHUSETTS USA.  Conference and Exhibition dedicated to enabling product development and market success of biomedical technologies and products based on optics and photonics. Boston, MA,

2. FACSS / SCIX 2014, SEPTEMBER 28 – OCTOBER 3, 2014 – GRAND SIERRA RESORT, RENO, NV.   In 1972, the Federation of Analytical Chemistry and Spectroscopy Societies (FACSS) was founded as a Federation of member organizations for the exchange of ideas at the forefront of analytical sciences. The Great Scientific Exchange (SCIX) is a premier meeting Analytical Chemistry and Allied Science. The objective of FACSS is to provide an international forum in which representatives of academic, industrial, and government institutions, from diverse scientific disciplines, can participate and cooperate in an effort to confront the challenges of complex analytical problems and share their knowledge.


Share this post:

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.
FSE: 20B

Related articles ...

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.